MIMEDX GROUP INC
MDXGNASDAQ🏆 #2323 by market capEarnings Nov 4US Equity
$4.32▲ $0.05 (+1.17%)
Market closed · at close1h—
24h▲ 1.2%
7d▲ 4.0%
14d▲ 2.4%
30d▲ 5.4%
1y▼ 40.3%
🏦Market Cap
$630M
Small Cap
📈Revenue Growth (YoY)
-2.4%
Declining
📊Gross Margin
78.8%
High
💵FCF Margin
19.5%
Healthy
⚖️P/S Ratio
1.8x
Cheap
Otter Score
46
Weak
📊
Analyst Ratings
Price
$4.32
Total
15
Raised
1
Lowered
2
Avg PT
$8.50
H / L
$10 / $7
| Institution | Action | Rating | Date |
|---|---|---|---|
Citizens | Reiterated | Market Outperform | 2026-04-30 |
Craig-Hallum | Reiterated | Buy | 2026-04-17 |
Cantor Fitzgerald | Reiterated | Overweight | 2026-02-17 |
Lake Street | Reiterated | Buy | 2026-01-20 |
Mizuho | Reiterated | Outperform | 2025-12-17 |
HC Wainwright & Co. | Reiterated | Buy | 2024-05-01 |
Northland Capital Markets | Reiterated | Outperform | 2021-07-26 |
Needham | Downgraded | Strong Buy → Hold | 2018-02-20 |
First Analysis | Downgraded | Equal Weight → Underweight | 2017-05-23 |
PiperJaffray | Reiterated | Overweight | 2017-03-03 |
UBS | Reiterated | Sell | 2016-12-12 |
Aegis Capital | Reiterated | Buy | 2016-11-08 |
Northland Securities | Upgraded | Market Perform → Outperform | 2015-10-30 |
Brean Capital | Reiterated | Buy | 2015-07-17 |
Canaccord Genuity | Reiterated | Buy | 2014-10-15 |
One row per institution, most recent rating